LON:GENI GENinCode (GENI) Share Price, News & Analysis GBX 1.50 +0.10 (+7.14%) As of 10:40 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About GENinCode Stock (LON:GENI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GENinCode alerts:Sign Up Key Stats Today's Range 1.30▼ 1.5050-Day Range 1.31▼ 2.5052-Week Range 1▼ 8.50Volume66,697 shsAverage Volume615,364 shsMarket Capitalization£2.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Read More Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENI Stock News HeadlinesGENinCode (LON:GENI) Trading 3.4% Higher - Here's WhyAugust 21, 2025 | americanbankingnews.comGENinCode Plc Successfully Passes All Resolutions at AGMJune 30, 2025 | tipranks.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 29 at 2:00 AM | Brownstone Research (Ad)GENinCode shares surge as loss narrows amid increased revenueJune 4, 2025 | lse.co.ukDiscovering UK Penny Stocks: GENinCode And 2 More Compelling PicksFebruary 25, 2025 | finance.yahoo.comGENinCode announces retail offer at 5.13% discountFebruary 14, 2025 | msn.comGENinCode secures £4 million in new funding roundFebruary 14, 2025 | msn.comMARKET REPORT: Investors turn bearish on online spread bettersJanuary 24, 2025 | msn.comSee More Headlines GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed this year? GENinCode's stock was trading at GBX 3.89 at the beginning of the year. Since then, GENI shares have decreased by 61.4% and is now trading at GBX 1.50. How were GENinCode's earnings last quarter? GENinCode Plc (LON:GENI) released its earnings results on Wednesday, June, 4th. The company reported ($2.53) earnings per share for the quarter. GENinCode had a negative trailing twelve-month return on equity of 289.74% and a negative net margin of 228.70%. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of GENinCode own? Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include QUALCOMM (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG). Company Calendar Last Earnings6/04/2025Today8/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryEntertainment Current SymbolLON:GENI CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees2,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (3.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.10 million Net Margins-228.70% Pretax MarginN/A Return on Equity-289.74% Return on Assets-63.99% Debt Debt-to-Equity Ratio9.28 Current Ratio2.60 Quick Ratio15.89 Sales & Book Value Annual Sales£2.67 million Price / Sales1.00 Cash FlowGBX 1.80 per share Price / Cash Flow0.83 Book ValueGBX 1.63 per share Price / Book0.92Miscellaneous Outstanding Shares177,407,519Free FloatN/AMarket Cap£2.66 million OptionableNot Optionable Beta0.66 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (LON:GENI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.